that was niall dickson talking to the bbc earlier.s of issuing the first batch of papers, where is the balance between reassuring the public that there are contingency plans in place thatis there are contingency plans in place that is alarming them when they think about some of the things that could be really quite problematic, next spring. i think the government through the brexit strategy is made very clear there won't be a food shortage and we will get the medicine that we need. they have been ultra—cautious on the medicine. people have you have contracts with the nhs will want to honour those contracts. the good news is that the government is not saying it wants to impose all sorts of barriers at our border and of course it is entirely in the government's control whether it makes it difficult to get medicines in through dover or not. but agencies are being urged for example to stockpile medicines. our health editor has been sounding out a lot of people in this field this morning who say actually stockpiling six weeks of medicines

let's discuss this with niall dickson, who's the co—chair of the brexit health alliance, a lobby groupu ra nces what you heard so far? any reassurances for you ? what you heard so far? any reassurances for you?” what you heard so far? any reassurances for you? i think there is an element of reassurance, the government is clearly hoping for the best but has recognised it must plan for the worst. there is no doubt that, in the area for example the supply of medicines, it does represent a serious risk, we will be an unprecedented territory. but the guidance coming out today, admittedly at high level, but starting to say we will need six weeks of stockpiles of every medicine, that where medicines have a short shelf life, we will need to arrange the potential of having air freight transport to avoid any blockages which there may be at the border. all these seem sensible measures and our members from the pharmaceutical industries as well as the nhs had been working with the government to develop this. that said, that is quite a lot more detail both on the pharmaceutical side still to be work